| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.088 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.6 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.082 | 0.6 |